Asset

CLARITY PHARMACEUTICALS LTD

CU6
equity
AUD $0.89
stockPerformance 0.015 (1.72%)
Updated: 20 Jan, 5:10 am UTC
03 Jan06 Jan09 Jan12 Jan15 Jan18 Jan20 Jan0.840.860.880.90.920.940.960.98
Description
Clarity Pharmaceuticals Ltd is an ASX-listed drug development company focused on the development and commercialization of innovative radiopharmaceuticals and cancer therapies. Its projects include the development of a novel therapy for cancer, the expansion of radiopharmaceuticals to new markets, and the development of novel imaging agents for use in drug development. The company's objectives are to create innovative and effective treatments that improve patient outcomes, reduce healthcare costs, and advance medical research.